An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness-Reference-Cited by-同舟云学术

An I436N substitution confers resistance of influenza A(H1N1)pdm09 viruses to multiple neuraminidase inhibitors without affecting viral fitness

Published:2018-03-01 Issue:3 Volume:99 Page:292-302
ISSN:0022-1317
Container-title:Journal of General Virology
language:en
Short-container-title:

Author:

Kwon Jin Jung¹,Choi Won-Suk¹,Jeong Ju Hwan¹,Kim Eun-Ha¹,Lee Ok-Jun¹,Yoon Sun-Woo²,Hwang Jungwon³,Webby Richard J.⁴,Govorkova Elena A.⁴,Choi Young Ki¹,Baek Yun Hee¹,Song Min-Suk¹

Affiliation:

1. College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju, Republic of Korea

2. Viral Infectious Disease Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

3. Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

4. Department of Infectious Diseases, St Jude Children’s Research Hospital, Memphis, TN, USA

Publisher

Microbiology Society

Subject

Virology

Reference35 articles.

1. Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus

2. Update: influenza activity - United States, September 28, 2008-January 31, 2009;MMWR Morb Mortal Wkly Rep,2009

3. Characteristics of a Widespread Community Cluster of H275Y Oseltamivir-Resistant A(H1N1)pdm09 Influenza in Australia

4. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis-North Carolina, 2009;MMWR Morb Mortal Wkly Rep,2009

5. The Case for Integrated Delivery Systems

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022–2023;The Journal of Infectious Diseases;2023-09-28

2. In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir;Nature Communications;2023-07-04

3. Evolution of Influenza Viruses—Drug Resistance, Treatment Options, and Prospects;International Journal of Molecular Sciences;2022-10-13

4. Influenza polymerase inhibitor resistance: Assessment of the current state of the art - A report of the isirv Antiviral group;Antiviral Research;2021-10

5. Substitutions at H134 and in the 430-loop region in influenza B neuraminidases can confer reduced susceptibility to multiple neuraminidase inhibitors;Antiviral Research;2020-10